Literature DB >> 15300652

Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism.

Thomas Foltynie1, Terry E Goldberg, Simon G J Lewis, Andrew D Blackwell, Bhaskar S Kolachana, Daniel R Weinberger, Trevor W Robbins, Roger A Barker.   

Abstract

Parkinson's disease (PD) patients show a range of executive deficits involving dopaminergic transmission in the prefrontal cortex. In this study, we have investigated the impact of catechol-O-methyl-transferase (COMT) val(158)met polymorphisms on performance of the Tower of London (TOL) test of planning by PD patients. Motor and cognitive assessments were performed on 288 patients as part of a population-based study of PD. These patients were subsequently genotyped for the COMT val(158)met polymorphism. Patients with high activity COMT genotypes performed significantly better at the TOL task than those with low activity genotypes. Subgroup analyses suggest that this effect is greatest in patients exposed to dopaminergic agents. We hypothesise that the inferior performance in patients with the low activity COMT genotype is attributable to a state of relative hyperdopaminergic activity in the dorsolateral prefrontal cortex compared with that in the striatum. We suggest that polymorphisms of common genes, which regulate central nervous system dopaminergic transmission, can influence some of the phenotypic manifestations of PD. Copyright 2004 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300652     DOI: 10.1002/mds.20118

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  39 in total

1.  The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome.

Authors:  Christina Zaleski; Anne S Bassett; Karen Tam; Andrea L Shugar; Eva W C Chow; Elizabeth McPherson
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

Review 2.  Dopamine overdose hypothesis: evidence and clinical implications.

Authors:  David E Vaillancourt; Daniel Schonfeld; Youngbin Kwak; Nicolaas I Bohnen; Rachael Seidler
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

Review 3.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

4.  Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.

Authors:  Ignacio F Mata; Catherine O Johnson; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Vivianna M Van Deerlin; Beate Ritz; Rebecca Rausch; Stewart A Factor; Cathy Wood-Siverio; Joseph F Quinn; Kathryn A Chung; Amie L Peterson-Hiller; Alberto J Espay; Fredy J Revilla; Johnna Devoto; Dora Yearout; Shu-Ching Hu; Brenna A Cholerton; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  Neurobiol Aging       Date:  2017-04-20       Impact factor: 4.673

5.  Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

Authors:  R N Alcalay; E Caccappolo; H Mejia-Santana; M -X Tang; L Rosado; M Orbe Reilly; D Ruiz; B Ross; M Verbitsky; S Kisselev; E Louis; C Comella; A Colcher; D Jennings; M Nance; S Bressman; W K Scott; C Tanner; S Mickel; H Andrews; C Waters; S Fahn; L Cote; S Frucht; B Ford; M Rezak; K Novak; J H Friedman; R Pfeiffer; L Marsh; B Hiner; A Siderowf; H Payami; E Molho; S Factor; R Ottman; L N Clark; K Marder
Journal:  Neurology       Date:  2012-03-21       Impact factor: 9.910

6.  DTI correlates of distinct cognitive impairments in Parkinson's disease.

Authors:  Zhong Zheng; Shirag Shemmassian; Christopher Wijekoon; Won Kim; Susan Y Bookheimer; Nader Pouratian
Journal:  Hum Brain Mapp       Date:  2013-02-18       Impact factor: 5.038

7.  Functional brain networks and cognitive deficits in Parkinson's disease.

Authors:  Hugo-Cesar Baggio; Roser Sala-Llonch; Bàrbara Segura; Maria-José Marti; Francesc Valldeoriola; Yaroslau Compta; Eduardo Tolosa; Carme Junqué
Journal:  Hum Brain Mapp       Date:  2014-03-17       Impact factor: 5.038

Review 8.  Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction.

Authors:  Johanna M Jarcho; Emeran A Mayer; Ziyue Karen Jiang; Natasha A Feier; Edythe D London
Journal:  Pain       Date:  2012-03-03       Impact factor: 6.961

Review 9.  Genetic Variation and Neuroplasticity: Role in Rehabilitation After Stroke.

Authors:  Jill Campbell Stewart; Steven C Cramer
Journal:  J Neurol Phys Ther       Date:  2017-07       Impact factor: 3.649

Review 10.  Genes, cognition and brain through a COMT lens.

Authors:  D Dickinson; B Elvevåg
Journal:  Neuroscience       Date:  2009-05-13       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.